These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 17601800

  • 1. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 2. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S, Tsujimoto T, Toyohira Y, Hayashida Y, Sasaguri Y, Ueta Y, Nakashima Y, Yanagihara N.
    Arterioscler Thromb Vasc Biol; 2004 Sep 20; 24(9):1682-8. PubMed ID: 15217805
    [Abstract] [Full Text] [Related]

  • 3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 4. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD, Ye JM, Fu XM, Wang XC, Ye JY, Wu XR, Hua P, Liao YQ, Xuan W, Duan JL, Li WY, Fu H, Xia ZH, Zhang X.
    Int J Mol Med; 2019 Feb 14; 43(2):749-760. PubMed ID: 30569164
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
    Kopaliani I, Jarzebska N, Billoff S, Kolouschek A, Martens-Lobenhoffer J, Bornstein SR, Bode-Böger SM, Ragavan VN, Weiss N, Mangoni AA, Deussen A, Rodionov RN.
    Am J Physiol Heart Circ Physiol; 2021 Nov 01; 321(5):H825-H838. PubMed ID: 34533401
    [Abstract] [Full Text] [Related]

  • 6. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
    Zhang P, Fassett JT, Zhu G, Li J, Hu X, Xu X, Chen Y, Bache RJ.
    Vasc Med; 2017 Jun 01; 22(3):179-188. PubMed ID: 28145161
    [Abstract] [Full Text] [Related]

  • 7. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
    Minakuchi H, Wakino S, Hosoya K, Sueyasu K, Hasegawa K, Shinozuka K, Yoshifuji A, Futatsugi K, Komatsu M, Kanda T, Tokuyama H, Hayashi K, Itoh H.
    Nephrol Dial Transplant; 2016 Mar 01; 31(3):413-23. PubMed ID: 26516203
    [Abstract] [Full Text] [Related]

  • 8. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Mar 01; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 9. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.
    Tanaka M, Sydow K, Gunawan F, Jacobi J, Tsao PS, Robbins RC, Cooke JP.
    Circulation; 2005 Sep 13; 112(11):1549-56. PubMed ID: 16144995
    [Abstract] [Full Text] [Related]

  • 10. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC, Conci E, Haubner BJ, Stocker EM, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B.
    Cardiovasc Res; 2007 Jul 15; 75(2):417-25. PubMed ID: 17559823
    [Abstract] [Full Text] [Related]

  • 11. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jul 15; 31(7):1540-6. PubMed ID: 21493890
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B, Nandi M, Kelly P, Wojciak-Stothard B, Fleming I, Leiper J.
    Vasc Med; 2010 Jun 15; 15(3):205-13. PubMed ID: 20219849
    [Abstract] [Full Text] [Related]

  • 13. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Atherosclerosis; 2010 Mar 15; 209(1):66-73. PubMed ID: 19775692
    [Abstract] [Full Text] [Related]

  • 14. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 15; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 15. Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
    De Gennaro Colonna V, Bonomo S, Ferrario P, Bianchi M, Berti M, Guazzi M, Manfredi B, Muller EE, Berti F, Rossoni G.
    Eur J Pharmacol; 2007 Feb 28; 557(2-3):178-85. PubMed ID: 17258196
    [Abstract] [Full Text] [Related]

  • 16. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells.
    Jiang DJ, Jia SJ, Dai Z, Li YJ.
    J Mol Cell Cardiol; 2006 Apr 28; 40(4):529-39. PubMed ID: 16516911
    [Abstract] [Full Text] [Related]

  • 17. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
    Konishi H, Sydow K, Cooke JP.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1099-105. PubMed ID: 17349891
    [Abstract] [Full Text] [Related]

  • 18. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.
    PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122
    [Abstract] [Full Text] [Related]

  • 19. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
    Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, Täger M, Bode-Böger SM.
    Hypertension; 2008 Mar 01; 51(3):696-703. PubMed ID: 18250362
    [Abstract] [Full Text] [Related]

  • 20. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C, Mowat F, Sayed H, Mehad M, Duluc L, Piper S, Luhmann U, Nandi M, Kelly P, Smith A, Ali R, Leiper J, Bainbridge J.
    Exp Eye Res; 2016 Jun 01; 147():148-155. PubMed ID: 27181226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.